2024-03-31-accounts - St Wilfrid's Hospice (Eastbourne)

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

CONTENTS					Page
Legal and administrative		information			I
Trustees' Report incorporating			a	Stri	2-18
Report
Independent	Auditor's	report			19 - 21
Consolidated	statement	of financial		acti	22
Charity and	Group balance sheets				23
Consolidated	statement	of cash flows			24
Notes to the	financial	statements			25 - 42

REGISTERED	REGISTERED	NAME		St Wilfrid's Hospice	St Wilfrid's Hospice	St Wilfrid's Hospice	(Eastbourne)	(Eastbourne)	(Eastbourne)	(Eastbourne)
CHARITY		NUMBER		283686
COMPANY		NUMBER		01594410
PRINCIPAL		OFFICE/REGISTERED	OFFICE	1 Broadwater	Way
				Eastboume
				East Sussex
				BN22 9PZ
PRESIDENT				HM The Queen
PATRONS				The Duke of Devonshire
				Mr David Dimbleby
				Dr Joan Hester
TRUSTEES				Mr S O'Leaiy	(Chair)
				Mr D Adams
				Dr M Barnes
				Mrs J Butler
				Ms L Chambers		(resigned		29 May			2024)
				Ms B Hobson
				Mr D Holdsworth
				Ms F Maclntyre
				Mr G Meyer
				Mrs M Richardson
				Mr D Turner
CHIEF	EXECtJTIVE			Mr C Twomey
LEADERSHIP		TEAM		Dr D Barclay	(Medical		Director)
				Ms A Dechamps		(Patient		&	Family			Support	Director)
				Mr D Mackenzie		(Finance		and		IT	Director)
				Mrs P Russell	(Development				Director)
				Mrs E Prodger	(Clinical			Services Director)					(appointed		2
				October 2023)
				Mrs R Bacon (Associate				Director			for	Clinical		Services)
				Mrs G Chandler		(Associate			Director			for People		Services)
				Dr L Free (Associate			Medical			Director)
				Mrs T Scmikker		(Associate			Director			for Quality
				Improvement)
AUDITORS				Haysmacintyre	LLP
				10 Queen Street		Place
				London
				EC4R 1AG

			2023/24	2022/23	Increase/decrease	Variance
			fk	Ek	Ek
Legacies			2,230	3,848	(1,618)
Donations	and	Gifts	2,027	1,805	222
Lottery			3 82	352	30	9
Trading			1,397	1,260	137	11

		2023-24	2022-23
		tk	tk
	Patient Care	7,803 (73%)	7,051 (75%)
	Fundraising	1,481 (14%)	1,237 (13%)
*	Trading	1,363 (13%)	1,154 (12%)

	2023/24	2022/23
Legacies	26%	40%
Gifts and Donations	24%	18%
Statutory Funding	27%	23%
Trading	16%	13%
Lottery	4%	4%
Investments/other	3%	2%

Risk identified	Risk identified								Mitigation
Uncertainty		of income			or escalation		of costs		*	Rolling	three-year	financial		plans	and
leading	to budget		deficit.							scenario	planning	including		detailed
										financial	modelling
									*	Utilise	legacy	income		projection
										planning	from external consultancy
									*	Achieve	effective	strategic	relationship
										with NHS Integrated Care			Board
									*	Installation of solar panels				to create
										energy resilience
									*	Regular	cashflow	reporting
									*	Reserves	policy in place with			monitor
										by Board	of Trustees ensuring			adequate
										reserves
Capacity	and	resilience		issues including					*	Establish	successful	partnership
establishment		of adequate			staffing	levels				working	to realise	beiefits	in	shared
										key roles
									*	Approved	People	Strategy	to	direct
										effective	workforce	planning
									*	Strong focus and resources			for staff
										wellbeing
									*	Effective	use of volunteer roles
									*	Effective	staff feedback mechanisms
										with action plans
Safeguarding		(used in		the broad		sense of			*	Safeguarding Committee in			place with
keeping	safe	from	harm).							Trustee as Chair
									*	Mandatory	training	in place	with
										monitor	of compliance
									*	Safeguarding risk		register to monitor
										and scnitinise risk
									*	Speak up policy and procedure
										including	whistleblowing and
										availability	of Freedom to Speak Up
										Guardians
									*	Safeguarding Lead		in role
Short/long-term		disniption			to business		caused by		*	Major incident and		business	continuity
major event or		systems failure								policy in	place with	annual	exercise		to
										test procedures
								It

					*	Fire risk assessment reviewed	bi-
						annually
					*	Infection prevention and control
						policies and procedures in place with
						audits
					*	Strengthened IT infrastnichires	with
						third pariy support included
Fraud,	theft	andcyber crime.			*	Payroll database implemented	with
						improved safety
					*	Building security upgraded including
						additional CCTV
					*	Cash handling policies and procedures
						in place
					*	Incident reporting encouraged	to
						identify trends and learning
						opportunities
					*	Improved firewall struchires
					*	Implementation of financial
						management database with	improved
						security
Information		governance	- data breach	or	*	Data protection and security	policies
other	data	error.				and procedures in place with	oversight
						by Data Protection and security
						steering group reporting to	Audit
						Committee
					ii	Key information governance	roles in
						place: IG Lead, Senior Information
						Risk Officer, Caldicott Guardian
					ii	Compliance with NHS Data	Security
						and Protection toolkit
					*	Mandatory training with compliance
						monitor in place

			Unrestricted	Restricted	Total	Total
			Funds	Funds	2024	2023
		Notes	E.	t
INCOME FROM:
Donations and Legacies		2	3,976,208	280,895	4,257,103	5,654,153
Charitable Activities
Stahitory Funding		2	1,697,672		1,697,672	1,692,638
Non-Statutory Funding		2	592,424		592,424	536,744
Other trading activities
Income from Trading		3	1,396,838		1,396,838	1,260,238
Income from Lottery			381,952		381,952	352,349
Investments		4	204,006		2 04,006	138,165
Other		5	19,498		19,498	56,334
Total Income			8,268,598	280,895	8,549,493	9,690,621
EXPENDITURE ON:
Raising Funds
Fundraising Costs		6	1,481,183		1,481,183	1,237,299
Trading Costs of Goods	Sold
and Other Costs		3	1,362,976		1,362,976	1,154,486
Charitable activities
In Patient		6	3,641,590	68,195	3,709,785	3,419,869
Therapies		6	511,258	16,642	527,900	507,946
Community Nursing		6	2,966,614	49,711	3,016,325	2,620,651
Patient & Family Support		6	432,556	116,500	549,056	502,525
Total Expenditure			10,396,177	251,048	10,647,225	9,442,776
Net income/(expenditure)
before net gains/(losses)	on		(2,127,579)	29,847	(2,097,732)	247,845
investments
Net gains/(losses) on		13	165,309		165,309	(145,827)
investments
Net income/(expenditure)			(1,962,270)	29,847	(1,932,423)	102,018
Gross transfers between	funds	19	14,762	(14,762)
Net movement in funds			(1,947,508)	15,085	(1,932,423)	102,018
Fund balances at1 April	2023		19,830,095	49,253	19,879,348	19,777,330
Fund balances at 31	March	20,21	17,882,587	64,338	17,946,925	19,879,348
2024

					Hospice
				2024	2023	2024	2023
			Notes	:E	t
FIXED ASSETS
Tangible assets			12	9,466,070	9,506,686	9 466 070	9,506 686
Investments			13	4,713,749	4,493,457	4 713 648	4 493,356
				14 ,179,819	14,000,143	14 179 718	14000042
CURRENT	ASSETS
Stocks				5,965	5,463	9,745	10,964
Debtors			14	2,178,580	2,986,786	2,143,665	2,932,554
Cash at bank and in hand				2,185,941	4,434,083	2,244,199	4,498,075
				4,370,486	7,426,332	4,397,609	7,441,593
CREDITORS:	amounts
falling due	within	one year	15	(606,945)	(1,549,641)	(630,402)	(1,562,287)
NET CURRENT		ASSETS		3,763,541	5,876,691	3,767,207	5,879,306
TOTAL ASSETS		LESS
CURRENT	LIABILITIES			17,943,360	19,876,834	17,946,925	19,879,348
NET ASSETS				17,943,360	19,876,834	17,946,925	19,879,348
FUNDS:
Restricted funds			18	64,338	49,253	64,338	49,253
Unrestricted	funds:
Designated	funds		19	12,310,482	13,911,275	13,443,963	13,911,275
Operating reserve			19	5,568,540	5,916,306	4,438,624	5,918,820
				17,943,360	19,876,834	17,946,925	19,879,348

								2024	2023
							Note
Cash flows from operating		activities:
Net cash provided by operating acaviaes							21	(2,051,916)	797,487
Cash flows from investing		activities:
Dividends, interest and rents from investments								204,006	138,165
Proceeds from the sale of	plant and equipment							192
Purchase of property, plant		and equipment						(351,175)	(138,437)
Purchase of investments								(596,900)	(1,387,600)
Disposal of investments								532,555	1,075,458
Movement in investment	cash							9,362	7,717
Net cash (used in) investing		activities						(201,960)	(304,697)
Change in cash and cash		equivalents	in	the reporting	period			(2,253,876)	(492,790)
Cash and cash equivalents		at the beginning		of the reporting		period		4,498,075	4,005,285
Cash and cash equivalents		at the end	of	the reporting		period		2,244,199	4,498,075

	ACCOUNTING POLICIES
	The principal accounting policies adopted, judgements and key sources of	judgement, estimation,		and uncertainty
	in the preparation of the financial statements are as follows:
	Statement of compliance
	The financial statements have been prepared in accordance with Accounting	and Reporting by	Charities:
	Statement of Recommended Practice applicable to charities preparing their	accounts in accordance		with	the
	Financial Reporting Standard applicable in the {JK and Republic of Ireland	(FRS 102) - (Chai'ities		SORP		Second
	Edition, effective 1 January 2019), the Financial Reporting Standard applicable in the UK and		Republic		of
	Ireland (FRS 102) and the Companies Act 2006.
	St Wilfrid's Hospice (Eastbourne) meets the definition of a public benefit entity under FRS 102.		ASsets and
	liabilities are initially recognised at historical cost or transaction value unless	otherwise stated in	the	relevant
	accounting policy note(s).
1.2	General information
	The charity is a private company limited by guarantee, incorporated in England and Waies (company number:
	01594410) and a charity in England and Wales (charity number: 283686). The charity's registered			office	is 1
	Broadwater Way, Eastbourne, East Sussex, BN22 9PZ.
1.3	Preparation of accounts on a going concern basis
	At the time of approving the financial statements, Trustees have a reasonable	expectation that the		charity		has
	adequate resources to continue in operational existence for the foreseeable	future. In addition,	through
	appropriate consideration of risks as part of its normal risk management processes and mitigating			actions		both
	already taken and available to be taken, the Trustees consider there are no material uncertainties		about the
	Charity's ability to continue as a going concern. The review of the Charity's	financial position,	reserves		levels
	and future plans gives Trustees confidence the Charity remains a going concern for the foreseeable			future.
1.4	Group financial statements
	The financial statements consolidate the results of the charity and its wholly	owned subsidiary	St	Wilfrid's
	Hospice Eastbourne Trading Company Limited (registered number: 02198239). The results of		the	wholly		owned
	subsidiaiy, St Wilfrid's Hospice (Eastbourne) Projects Limited, has not been consolidated into		these financial
	statements as its results are immaterial to the charity and group. A separate	Statement of Financial		Activities		and
	Income and Expenditure Account for the charity has not been presented because the charity has taken advantage
	of the exemption afforded by section 408 of the Companies Act 2006. The	registered office for	these subsidiaries
	is the same as the parent.

1.9	Financial instruments
	The charity only has financial assets and financial liabilities of a kind			that qualify	as basic	financial		instruments.
	Basic financial instruments are initially	recognised at transaction value		and subsequently measured				at	their
	settlement value with the exception of	bank loans which are subsequently measured			at amortised		cost		using			the
	effective interest method.
1.10	Investments
	Investments are a fomi of basic financial	instniments and are initially shown in the financial				statements		at		market
	value. Movements in the market values	of investments are shown as unrealised gains			and losses in the			Statement				of
	Financial Activities.
	Profits and losses on the realisation of investments are shown as realised			gains and losses in the Statement						of
	Financial Activities. Realised gains and	losses on investments are calculated between			sales proceeds		and		their
	opening cariying values or their purchase value if acquired subsequent		to the first day of the			financial		year.
	Unrealised gains and losses are calculated as the difference between the			fair value at	the year	end and		their		carrying
	value. Realised and unrealised investment	gains and losses are combined		in the Statement of		Financial		Activities.
1.11	Stock
	Stock consists of purchased goods for resale. Stocks are valued at the		lower of cost		and net	realisable			value.
	Items donated for resale or distribution	are not included in the financial		statements	untilthey	are sold or
	distributed.
1.12	Creditors and provisions
	Creditors and provisions are recognised	where the charity has a present		obligation	resulting	from a past				event		that
	will probably result in the transfer of funds to a third party and the amount due to settle the					obligation			can be
	measured or estimated reliably. Creditors and provisions are normally			recognised at their settlement				amount				after
	allowing for any trade discounts due.
1.13	Debtors
	Trade and other debtors are recognised	at the settlement amount due after any trade			discount	offered.
	Prepayments are valued at the amount	prepaid net of any trade discounts		due.
1.14	Cash at bank and in hand
	Cash at bank and cash in hand includes	cash and short temi highly liquid investments			with	a short	maturity				of
	three months or less from the date of acquisition or opening of the deposit or similar				account.
1.15	Pensions
	The charity operates a defined contribution pension scheme. Contributions			are charged in the accounts					as they
	become payable in accordance with the	rules ofthe scheme.
1.16	Donated goods
	The Tnistees consider the valuation of donated goods for resale at the		point of receipt is impractical,					due		to	the
	high volume of low value items and the	administrative costs involved	in valuation.		Goods donated		for		resale			are
	therefore recognised in the accounts at the point of sale.
1.17	Fund accounting
	General funds are unrestricted funds which are available for use at the		discretion of		the trustees in		furtherance					of
	the general objectives of the charity and	which have not been designated		for other purposes.
	Designated funds comprise unrestricted	funds that have been set aside	by the trustees for particular				purposes.					The
	aim and use of each designated fund is set out in the notes to the financial			statements.
	Restricted funds comprise funds received	for a specific expenditure as	specified by		the donor. The		aim		and use of
	each restricted fund is set out in the notes to the financial statements.

DONATIONS, LEGACIES	AND	Unrestricted	Restricted
ST ATUTORY FUNDING		Funds	Funds	2024
Donations and Gifts		1 ,745,795	280,895	2,026,690
Legacies Receivable		2,230,413		2,230,413
		3,976,208	280,895	4,257,103
Grants Receivable for Core	Activities
Statutoiy Funding		1,697,672		1,697,672
Non-Statutory Funding		592,424		592,424
		6,266,304	280,895	6,547,199
DONATIONS, LEGACIES	AND	Unrestricted	Restricted
ST ATUTORY FUNDING		Funds	Funds	2023
Prior Year - 2023
Donations and Gifts		1,550,470	255,083	1,805,553
Legacies Receivable		3,848,600		3,848,600
		5,399,070	255,083	5,654,153
Grants Receivable for Core	Activities
Statutory Funding		1,692,638		1,692,638
Non-Statutory Funding		536,744		536,744
		7,628,452	255,083	7,883,535

ACTIVITIES	FOR GENERATING
Trading income	and costs
Trading income
Donated goods	income	1,132,944		1,048,977
Bought in goods	income	34,753		43,682
Street cafi: income		229,141		167,579
Other operating	income
			1,396,838		1,260,238
Trading expenses
Cost of sales		48,284		35,877
Street caf6 costs		207,442		155,462
Staff expenses		517,954		475,443
Propeity expenses		472,613		351,518
Administration	expenses	99,004		135,815
Dilapidations/Depreciation		17,679		371
			1,362,976		1,154,486
Less interest received		(503)		(170)
			1,362,473		1,154,316
Total (deficit)/surplus			34,365		105,922
Number of shops			12		11

	INVESTMENT	INCOME	INCOME	INCOME	tJNRESTRICTED			2024	2023
	Rental income	from	investment		properties			30,923	25,328
	Income from listed		investments					83 482	80 669
	Interest receivable							89 601	32,168
								204 006	138,165
	OTHER INCOME		-	UNRESTRICTED				2024	2023
	Other Income							19 498	56,334
								19 498	56,334
6.	TOTAL EXPENDITURE					Other	Support
					Staff	Direct	Costs	Total
					Costs	Costs	Allocation	2024
								;E
	Charitable expenditure
	Primary costs
	In Patient				2,196,242	224,417	1,289,126	3,709,785
	Therapies				331,776	20,334	175,790	527,900
	Community	Nursing			1,734,602	31,661	1,250,062	3,016,325
	Patient & Family		Support		346,326	7,408	195,322	549,056
					4,608,946	283,820	2,910,300	7,803,066
	Costs of generating			funds
	Non-charitable	Trading			517,954	845,022		1,362,976
	Fundraising				569,815	481,660	429 708	1,481,183
					5,696,715	1,610,502	3,340,008	10,647,225
	SUPPORT COSTS							2024
								Total
	Support staff							1.678.955
	Office							389 437
	Premises and	utilities						1.244 424
	Governance							27 192
								3,340,008
	GOVERNANCE		COSTS
	Legal and professional							8,892
	Auditors' remuneration							18,300
								27,192

Prior Year	-	2023
				Staff	Other	Support	Total
					Direct	Costs
				Costs	Costs	Allocation	2023
Charitable	expenditure
Primary costs
In Patient				2,031,113	156,330	1,232,426	3,419,869
Therapies Community		Nursing		311,868 1,534,596	22,497 44,568	173,581 1,041,487	507,946 2,620,651
Patient &	Family Support			303,296	8,290	190,939	502,525
				4,180,873	231,685	2,638,433	7,050,991
Costs of generating			funds
Non-charitable		trading		475,443	679,043		1,154,486
Fundraising				497,734	409,761	329,804	1,237,299
				5,154,050	1,320,489	2,968,237	9,442,776
SUPPORT	COSTS						2023
							Total
Support staff Office							1 ,496,008 208,669
Premises and utilities							1,237,405
Governance							26,155
							2,968,237
GOVERNANCE		COSTS
Legal and professional							6,940
Auditors' remuneration							19,215
							26,155

NET INCOME/(EXPENDITURE)	2024	2023
Net income is stated after:
Auditors' remuneration
- Audit services	19,500	17,015
- Non-audit services	1,600	2,200
Depreciation	391,791	429,359

												Hospice	and Group
EMPLOYEES												2024	2023
												Number	Number
The average		monthly		number		of	employees	during		the	year was:
In Patient												66
Therapies												9
Community		Nursing										64
Patient &	Family		Support									10
Support staff												55
Fundraising												22
Retail												25
												251
The full-time		equivalent			number		of employees		at	March	was:
Inpatient Therapies												42 7	38 8
Community Patient &	Nursing Family Support											39 7	38 7
Support staff Fundraising												43 17	36 15
Retail												20	17
												175	159
Etnployment		costs
Wages and		salaries										6,323,867	5,685,319
National	insurance											543,258	496,698
Pension	costs											508,545	452,264
Redundancy		costs											15,777
												7,375,670	6,650,058

The nu f60,000	mber of employees whose annual remun or more were:	eration was
		2024	2023
		Number	Number
E60,000	- E70,000		1
E70,000	- f80,000		2
f80,000	- f90,000
E90,000	- EIO0,000		l
EIO0,000	- fll0,000
El 10,000	- fl20,000

rs ospce (Eastbourne) under a is shown below.	ift Aid Declaration. A summary of its tr	ading results
	2024	2023
	t	t
Turnover Other operating income	263,894	211,261
Expenditure	(234,939)	(177,917)
Operating(loss)/profit Interestreceivable	28,955	33,344
	503	170
(Loss)/profit for the year	29,458	33,514
	2024	2023
Tangible fixed ASSETS
Current assets Current liabilities	86,259 (54,185)	92,742 (57,890)
Net (liabilities)/assets	32,074	34,852
Capital and reserves	32,074	34,852

				Fixtures
Hospice	Land and	Computer	Plant and	And	Motor
	Buildings	Equipment	equipment	Fittings	Vehicles	Total
				t	t	t
Cost
At 1 April 2023	11,061,021	522,209	140,435	601,501	86,904	12,412,070
Additions		33,165	292,609	25,401		351,175
Disposals					(3,200)	(3,200)
At 31 March 2024	11,061,021	555,374	433,044	626,902	83,704	12,760,045
Depreciation
At l April 2023	1 ,922,858	424,674	107,987	385,795	64,070	2,905,384
Charge for the year	2 02,094	75,647	35,873	70,525	7,652	391,791
On disposals					(3,200)	(3,200)
At 31 March 2024	2,124,952	500,321	143,860	456,320	68,522	3,293,975
Net Book Value
At 31 March 2024	8,936,069	55,053	289,184	170,582	15,182	9,466,070
At 31 March 2023	9,138,163	97,535	32,448	215,706	22,834	9,506,686
Group
Cost
At I April 2023	11,061,021	523,859	140,435	601,501	86,904	12,413,720
Additions		33,165	292,609	25,401		351,175
Disposals					(3,200)	(3,200)
At 31 March 2024	11,061,021	557,024	433,044	626,902	83,704	12,761,695
Depreciation
At 1 April 2023	1,922,858	426,324	107,987	385,795	64,070	2,907,034
Charge for the year	202,094	75,647	35,873	70,525	7,652	391,791
On disposals					(3,200)	(3,200)
At 31 March 2024	2,124,952	501,971	143,860	456,320	68,522	3,295,626
Net Book Value
At 31 March 2024	8,936,069	55,053	289,184	170,582	15,182	9,466,070
At 31 March 2023	9,138,163	97,535	32,448	215,706	22,834	9,506,686

FIXED ASSET HOSPICE	INVES	T	ME	NTS	- GROU	P AND
							Investment	Listed	Total
							Properties	Investments	Investments
Market value at 1 April 2023 Additions at market value Disposals at cost Revaluation							940,000	3,553,356 596,900 (532,555)	4 493,356 5 96,900 (532,555)
Movement in investment			cash					165,309 (9,362)	165,309 (9,362)
Group Market March 2024	value		at	31			940,000	3,773,648	4,713,648
Investment in subsidiaries
Share capital
.St Wilfrid's Hospice		(Eastbourne)			Projects	Limited
. St Wilfrid's Hospice		Eastbourne			Trading	Company
Limited
Hospice Market March 2024	value		at	31					4,713,749
Historical cost:
At 31 March 2024							516,851	3,613,026	4,129,877
At 31 March 2023							516,851	3,598,296	4,115,147

DEBTORS					Group
		2024	2023	2024	2023
		t			t
Legacies Trade debtors Amounts owed by group undertakings		1 ,635,454 113,148 59,136	1,483,701 889,742 54,232	1,635,454 113,868	1,483,701 889,742
Prepayments Other debtors	& accrued income	334,328 36,514	471,531 87,579	357,829 36,514	471,531 87,579
		2,178,580	2,986,786	2,143,665	2,932,554

CREDITORS: within one year	amounts	falling	2024	2023	2024	2023
Trade creditors			134,099	308,311	134,509	308,311
Taxes and social Other creditors	security	costs	151,614 64,257	109,360 87,280	151,614 64,309	109,360 97,511
Accruals			98,124	53,745	121,119	56,160
Deferred income			158,851	990,945	158,851	990,945
			606,945	1,549,641	630,402	1,562,287

RESTRICTED INCOME	23/24	Balance	Movement	in funds	Balance
		I April			31 March
		2023	Income	Expenditure	2024
				& Transfers
				;E
In Patient Unit		1,213	48,967	(50,180)
In Patient Unit Refurbishment Cuddle Bed Appeal Hospice In the Community			15,520 18 750 59 706	(59,868)	15,520 18,750 322
Therapies & Living Well Patient & Family Support	Service		60,309	(266) (60,309)	534
Care for the Carers Other Restricted Funds			30,000 5,156	(30,000) (5,156)
Anne Beech Bursary Fund IPU Capital & Improving Minibus Appeal BBC Children in Need & Spring Appeal 2023 Syringe Driver Appeal	Patient Care Appeal The Seahorse Project	6,210 656 7,595 18,620 9,332	30,092 5,373 7,022	(656) (355) (26,645) (16,021) (16,354)	6,210 7,240 3,447 1972
Wellbeing Appeal		4,343			4,343
		49,253	280,895	(265,809)	64,338

Prior Year Restricted Funds	Prior Year Restricted Funds	Balance	Movement	in funds	Balance at
		l April			31 March
		2022	Income	Expenditure	2023
				Transfers
[n Patient Unit Hospice In the Community Therapies & Living Well	Service		4 630 44 677 5 800	(3,417) (46,283) (5,000)	1,213 484 800
Patient & Family Support			80,538	(80,538)
Other Restricted Funds		14,757	56,918	(71,675)
Anne Beech Bursaiy Fund			6,210		6,210
IPU Capital & Improving Minibus Appeal	Patient Care Appeal	26,590 11,651		(25,934) (4,056)	656 7,595
Seahorse Project		6,389	28,358	(34,7 47)
Spirihial Support Appeal Spring Appeal 2023 Syringe Driver Appeal Wellbeing Appeal		1,692 31,561	18,620 9,332	(1,692) (27,218)	18,620 9,332 4,343
		94,730	255,083	(300,560)	49,253

		Balanceat		Movementinfunds	Movementinfunds		Balanceat
		lApril					31March
		2023	Income	Expenditure	Gains/(losses)	Transfers	2024
		t	t	t	t	t	t
Asset Management Reserve Legacy Eqrialisation Reserve Strategic Development Reserve Fixed Asset Reserve Property Revaluation Reserve		700,000 2,560,177 954,412 9,506,686 190,000				(426,696) (40,616)	700,000 2,133,481 954,412 9,466,070 190,000
Designated funds		13,911,275				(467,312)	13,443,963
General funds		5,918,820	8,268,598	(10,396,177)	165,309	482,074	4,438,624
Total Unrestricted	Funds	19,830,095	8,268,598	(10,396,177)	165,309	14,762	17,882,587
Restricted Funds		49,253	280,895	(251,048)		(14,762)	64,338
Total Reserves		19,879,348	8,549,493	(10,647,225)	165,309		17,946,925
		Balance at		Movement	in funds		Balance at
		I April					31 March
		2022	Income	Expenditure	Gains/(losses)	Transfers	2023
Asset Management Reserve Legacy Equalisation Reserve Strategic Development Reserve Fixed Asset Reserve Revaluation Reserve		700.000 2.560.177 954.412 9.817.946 185.000		E	E 5,000	E - (311,260) -	E 700,000 2,560,177 954,412 9,506,686 190,000
Designated funds		14,217,535			5,000	(311,260)	13,911,275
General funds		5,465,065	9,435,537	(9,189,924)	(150,827)	358,968	5,918,820
Total Unrestricted	Funds	19,682,600	9,435,537	(9,189,924)	(145,827)	47,708	19,830,095
Restricted Funds		94,730	255,083	(252,852)		(47,708)	49,253
Total Reserves		19,771330	9,690,620	(9,442,776)	(145,827)		19,879,348

ANALYSIS OF NET ASSETS	ANALYSIS OF NET ASSETS	BETWEEN	BETWEEN		General	Designated	Restricted
FUNDS					Funds	Funds	Funds	Total
							t
Fund balances at 31 March	2024 are		represented	by:
Tangible Fixed Assets Fixed Asset Investments					4,713,648	9,466,070		9,466,070 4,713,648
Current Assets					355,378	3,977,893	64,338	4,397,609
Creditors: amounts falling	due within		one year		(630,402)			(630,402)
					4,438,624	13,443,963	64,338	17,946,925
ANALYSIS OF NET ASSETS		BETWEEN			General	Designated	Restricted
FUNDS - Prior Year					Funds	Funds	Funds	Total
Fund balances at 31 March	2023 are		represented	by:
Tangible Fixed ASsetS						9,506,686		9,506,686
Fixed Asset Investments					4,493,356			4,493,356
Current Assets					2,987,750	4,404,589	49,253	7,441,593
Creditors: amounts falling	due	within	one year		(1,562,287)			(1,562,287)
					5,918,819	13,911,275	49,253	19,879,348

21.	RECONCILIATION					OF NET	OF NET		INCOME	INCOME	TO	2024	2023
	NET CASH FLOW				FROM		OPERATmG				ACTIVITIES
	Net income for	the		reporting				period		(as per the
	statement of financial					activities)						(1,932,423)	102,018
	Adjustments for:
	Depreciation charges											391,791	429,359
	Loss on Disposal	of		Fixed ASSets									20,340
	Losses/(Gains)	on	investments									(165,309)	145,827
	Dividends, interest		and			rent from			investments			(204,006)	(138,165)
	(Profit)/loss on	the	sale			of fixed		assets				(192)
	Decrease/(increase)			in		stocks						1,219	1,918
	Decrease/(increase)			in		debtors						788,889	2 59,098
	Increase/(decrease)			in	creditors							(931,885)	(22,908)
	Net cash provided			by		operating			activities			(2,051,916)	797,487
22.	OPF,RATING	IJ,ASES				COMMn'MENTS						2024	2023
	Group Leases:
	Within one year											3,034	14,026
	Within two to five		years									38,765	40,629
												'N,199	54,655
	Charity Leases:
	Within one year											3,034	14,026
	Within two to five		years									38,765	40,629
												41,799	54,655

				Unrestricted	Restricted	Total	Total
				Funds	Funds	2023	2022
			Notes	t	t		t
INCOME FROM:
Donations and Legacies			2	5,399,070	255,083	5,654,253	4,673,778
Charitable Activities
Stahitory Funding			2	1,692,638		1,692,638	2,131,836
Non-Statutory Funding			2	536,744		536,744	534,813
Other trading activities
Income from Trading			3	1,260,238		1,260,238	1 ,135,044
Income from Lottery				352,349		352,349	362,300
Investments			4	138,165		138,165	60,763
Other			5	56,334		56,334	21,767
Total Income				9,435,538	255,083	9,690,621	8,920,301
EXPENDITURE ON:
Raising Funds
Fundraising Costs			6	1,229,446	7,853	1,237,299	956,198
Trading Costs of Goods		Sold
and Other Costs			3	1,154,486		1,154,486	968,999
Charitable activities
In Patient			6	3,384,537	35,332	3,419,869	3,578,219
Therapies			6	4 78,704	29,242	507,946	337,767
Community Nursing			6	2,561,750	58,901	2,620,651	2,107,777
Patient & Family Support			6	isi,ooi	121,524	502,525	355,612
Total Expenditure				9,189,924	252,852	9,442,776	8,304,572
Net income/(expenditure)
before net gains/(losses)		on		245,614	2,231	247,845	615,729
investnnents
Net gains/(losses) on			13	(145,827)		(145,827)	253,288
investments
Netincome/(expenditure)				99,787	2,231	102,018	869,017
Gross transfers between	funds		19	47,708	(47,708)
Net movement in funds				147,495	(45,477)	102,018	869,017
Fund balances at 1 April	2022			19,682,600	94,730	19,777,330	18,908,313
Fund balances at 31	March		20,21	19,830,095	49,253	19,879,348	19,777,330
2023